U.S. markets open in 7 hours 37 minutes
  • S&P Futures

    4,413.75
    +24.25 (+0.55%)
     
  • Dow Futures

    34,998.00
    +166.00 (+0.48%)
     
  • Nasdaq Futures

    15,038.00
    +82.25 (+0.55%)
     
  • Russell 2000 Futures

    2,240.70
    +19.10 (+0.86%)
     
  • Crude Oil

    73.25
    -0.70 (-0.95%)
     
  • Gold

    1,813.80
    -3.40 (-0.19%)
     
  • Silver

    25.58
    +0.03 (+0.13%)
     
  • EUR/USD

    1.1876
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.2390
    0.0000 (0.00%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3908
    +0.0001 (+0.01%)
     
  • USD/JPY

    109.6500
    +0.0350 (+0.03%)
     
  • BTC-USD

    39,785.76
    -2,100.05 (-5.01%)
     
  • CMC Crypto 200

    964.50
    +14.60 (+1.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,807.96
    +524.37 (+1.92%)
     

Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year?

·2 min read

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Axcella Health (AXLA) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Axcella Health is one of 887 individual stocks in the Medical sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. AXLA is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for AXLA's full-year earnings has moved 35.51% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the latest available data, AXLA has gained about 34.41% so far this year. Meanwhile, the Medical sector has returned an average of 0.17% on a year-to-date basis. This shows that Axcella Health is outperforming its peers so far this year.

Breaking things down more, AXLA is a member of the Medical - Biomedical and Genetics industry, which includes 381 individual companies and currently sits at #50 in the Zacks Industry Rank. On average, stocks in this group have gained 13.57% this year, meaning that AXLA is performing better in terms of year-to-date returns.

AXLA will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Axcella Health Inc. (AXLA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research